Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability

被引:136
作者
Dhumal, Ravindra S. [1 ]
Biradar, Shailesh V. [1 ]
Yamamura, Shigeo [2 ]
Paradkar, Anant R. [1 ,3 ]
York, Peter [3 ]
机构
[1] Bharati Vidyapeeth Univ, Poona Coll Pharm & Res Ctr, Dept Pharmaceut, Pune 411038, Maharashtra, India
[2] Josai Int Univ, Dept Pharmaceut Sci, Chiba, Japan
[3] Univ Bradford, Inst Pharmaceut Innovat, Bradford BD7 1DP, W Yorkshire, England
关键词
cefuroxime axetil; sonoprecipitation; amorphous; nanoparticles; bioavailability;
D O I
10.1016/j.ejpb.2008.04.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present work was to prepare amorphous discreet nanoparticles by sonoprecipitation method for enhancing oral bioavailability of cefuroxime axetil (CA), a poorly water-soluble drug. CA nanoparticles (SONO-CA) were prepared by sonoprecipitation and compared with particles obtained by precipitation without sonication (PPT-CA) and amorphous CA obtained by spray drying. Spray drying present broad particle size distribution (PSD) with mean particle size of 10 pin and low percent yield, whereas, precipitation without sonication resulted in large amorphous aggregates with broad PSD. During sonoprecipitation, particle size and yield improve with an increase in the amplitude of sonication and lowering the operation temperature due to instantaneous supersaturation and nucleation. The overall symmetry and purity of CA molecule was maintained as confirmed by FTIR and HPLC, respectively. All the three methods resulted in the formation of amorphous CA with only sonoprecipitation resulting in uniform sized nanoparticles. Sonoprecipitated CA nanoparticles showed enhanced dissolution rate and oral bioavailability in Wistar rat due to an increased solubility attributed to combination of effects like amorphization and nanonization with increased surface area and reduced diffusion pathway. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 21 条
[1]   Preparation and characterization of amorphous cefuroxime axetil drug nanoparticles with novel technology: high-gravity antisolvent precipitation [J].
Chen, Jian-Feng ;
Zhang, Ji-Yao ;
Shen, Zhi-Gang ;
Zhong, Jie ;
Yun, Jimmy .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2006, 45 (25) :8723-8727
[2]  
Crisp H.A., 1989, U.S. Patent, Patent No. [4,820,1833, 48201833]
[3]  
CRISP HA, 1985, Patent No. 4562181
[4]   Ultrasound-assisted crystallization (sonocrystallization) [J].
de Castro, M. D. Luque ;
Priego-Capote, F. .
ULTRASONICS SONOCHEMISTRY, 2007, 14 (06) :717-724
[5]   EFFECT OF DOSE AND FOOD ON THE BIOAVAILABILITY OF CEFUROXIME AXETIL [J].
FINN, A ;
STRAUGHN, A ;
MEYER, M ;
CHUBB, J .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1987, 8 (06) :519-526
[6]   Effect of ultrasound on anti-solvent crystallization process [J].
Guo, Z ;
Zhang, M ;
Li, H ;
Wang, J ;
Kougoulos, E .
JOURNAL OF CRYSTAL GROWTH, 2005, 273 (3-4) :555-563
[7]   Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids [J].
Jun, SW ;
Kim, MS ;
Jo, GH ;
Lee, S ;
Woo, JS ;
Park, JS ;
Hwang, SJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (12) :1529-1537
[8]   Nanosizing - Oral formulation development and biopharmaceutical evaluation [J].
Kesisoglou, Filippos ;
Panmai, Santipharp ;
Wu, Yunhui .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :631-644
[9]   Rapid sonocrystallization in the salting-out process [J].
Li, H ;
Wang, JK ;
Bao, Y ;
Guo, ZC ;
Zhang, MY .
JOURNAL OF CRYSTAL GROWTH, 2003, 247 (1-2) :192-198
[10]   Crystallization of glycine with ultrasound [J].
Louhi-Kultanen, Marjatta ;
Karjalainen, Mija ;
Rantanen, Jukka ;
Huhtanen, Mikko ;
Kallas, Juha .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 320 (1-2) :23-29